24 Jun

How Long Will Facebook’s Libra Fuel Bitcoin Rally?

WRITTEN BY Mike Sonnenberg

Bitcoin at $11,000

We wrote about Bitcoin (BTC-USD) last Monday, a day before the launch of Facebook’s cryptocurrency named Libra. Well, Bitcoin has continued to surge since then.

In the past week, Bitcoin has surged 19% to cross the $11,000 mark, which takes the gains of the most popular cryptocurrency (so far) to 36% over the past month and 77% over the past year. Last week, the S&P 500 gained 2.2%. The SPDR S&P 500 ETF (SPY) gained 1.64% last week. The ETF tracks the S&P 500 Index.

What’s fueling the rally?

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries. Interestingly, payment behemoths like Visa (V), Mastercard (MA), and PayPal (PYPL), whose business is threatened by the emergence of cryptocurrencies, are also part of the founding team.

Other major cryptocurrencies

Ethereum gained 14% in the past one week and 23% in the last one month. Smaller cryptos like Stellar Lumens have seen pricing pressure as major cryptos consolidate their position. Stellar Lumens has lost 1.63% in the past week.

Latest articles

On November 14, The George Soros Fund Management LLC filed 13F. The firm's total market value was around $3.6 billion at the end of Q3 2019.

Tesla (TSLA) stock short sellers seem to be getting exasperated. Notably, Tesla stock has been the short sellers’ favorite.

In the week that ended on November 15, natural gas prices fell 3.5% and settled at 2.688 per MMBtu (million British thermal units).

The Dow Jones Index (DIA) and S&P 500 (SPY) are trading at record highs and on Friday the Dow Jones crossed the 28,000 level for the first time.

Goldman Sachs (GS) settled a lawsuit that alleged it rigged bond prices. Also, Deutsche Bank agreed to pay a fine of $15 million to settle a lawsuit.

In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.